Company Filing History:
Years Active: 2025
Title: Sherie Duncan: Innovator in Antibody Research
Introduction
Sherie Duncan is a prominent inventor based in South San Francisco, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in immune responses.
Latest Patents
Sherie Duncan holds a patent for "Anti-TREM2 antibodies and methods of use thereof." This patent describes antibodies that specifically bind to the human triggering receptor expressed on myeloid cells 2 (TREM2) protein. In various embodiments, the antibody is designed to decrease levels of soluble TREM2 (sTREM2) and enhance TREM2 activity, showcasing her innovative approach to addressing immune system challenges.
Career Highlights
Duncan is currently employed at Denali Therapeutics Inc., a company known for its focus on developing therapies for neurodegenerative diseases. Her work at Denali Therapeutics highlights her commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout her career, Sherie has collaborated with notable colleagues, including Mark S. Dennis and Kathleen Lisaingo. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Sherie Duncan's work in antibody research exemplifies the innovative spirit of modern biotechnology. Her contributions are paving the way for new therapeutic approaches in treating diseases related to the immune system.